[1] 严霜霜,尹立雪.NAFLD心血管并发症超声心动图研究进展.中华超声影像学杂志,2018,27(6): 545-548. [2] Issa D, Albeldawi M, Lopez R, et al. Hematocrit levels and red blood cell indices in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol, 2014, 26(3): 363-364. [3] Katoh S, Peltonen M, Wada T, et al. Fatty liver and serum cholinesterase are independently correlated with HbA1c levels: cross-sectional analysis of 5384 people .J Int Med Res, 2014, 42(2): 542-553. [4] Sherwani SI, Khan HA, Ekhzaimy A, et al. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insig, 2016, 11(10): 95-104. [5] Prystupa A, Kiciński P, Sak J, et al. Proinflammatory cytokines (IL-1α, IL-6) and hepatocyte growth factor in patients with alcoholic liver cirrhosis. Gastroenterol Res Pract, 2015, 12(6): 1-7. [6] Hossain IA, Rahman Shah MM, Rahman MK, et al. Gamma glutamyl transferase is an independent determinant for the association of insulin resistance with nonalcoholic fatty liver disease in Bangladeshi adults: Association of GGT and HOMA-IR with NAFLD. Diabetes Metab Syndr, 2016, 10(1): 25-29. [7] Kawanaka M, Nishino K, Oka T, et al. Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease.Hepat Med, 2015, 7(1): 29-35. [8] 邵庆华, 郑盛, 杨涓, 等. 非酒精性脂肪性肝病患者血清糖化血红蛋白水平变化研究. 实用肝脏病杂志, 2016, 19(2): 175-179. [9] Mohan A, Reddy SA, Sachan A, et al. Derivation and validation of glycosylated haemoglobin(HbA1c)cut-off value as a diagnostic test for type 2 diabetes in south Indian population. Ind J Med Res, 2016, 144(2): 220-228. [10] 杨毅, 韩晨阳, 官俏兵, 等. 白细胞介素17通过促进巨噬细胞M1型极化调控小鼠非酒精性脂肪性肝病组织炎症反应的机制. 中华肝脏病杂志, 2018, 26(12): 916-921. [11] Bhala N, George J. The burden of non-alcoholic fatty liver disease (NAFLD) in the Asia pacific region. Curr Hepatol Rep, 2015, 14(2): 77-86. [12] Mahale AR, Prabhu SD, Nachiappan M, et al. Clinical relevance of reporting fatty liver on ultrasound in asymptomatic patients during routine health checkups.J Int Med Res, 2018, 46(11): 4447-4454. [13] 陈长喜, 杜娟, 徐益敏, 等. 血清糖化血红蛋白对非酒精性脂肪性肝病发病风险的预测价值. 中华肝脏病杂志, 2018, 26(10): 765-770. [14] 陈长喜, 杜娟, 徐益敏, 等. 中老年人NAFLD与糖化血红蛋白关系的流行病学研究. 中华内科杂志, 2015, 54(6): 517-520. [15] Shi DM, Dong FY, Zhang F, et al. IL-6 trans-signaling in an L-02 fatty liver cell model induced with sodium oleate and sodium palmitate. World Chin J Digestol, 2014, 22(34): 5235-5241. [16] Schmidt-Arras D, Rose-John S. IL-6 pathway in the liver: from physiopathology to therapy. J Hepatol, 2016, 64(6): 1403-1415. [17] Zaki ME, Nazif HK, Kandeel W, et al. IL-6 174G/C polymorphism in obese adolescents with nonalcoholic fatty liver disease and its relation to metabolic and biochemical markers. Middle East J Med Genet, 2016, 5(1): 20-25. [18] Zhang F, Jiang W, Li X, et al. The role of intrahepatic B cells in non-alcoholic fatty liver disease through secretion of pro-inflammatory cytokines and regulation of intrahepatic T cells. J Dig Dis, 2016, 17(7): 464-474. [19] Olteanu S, Kandel-Kfir M, Shaish A, et al. Lack of interleukin-1α in Kupffer cells attenuates liver inflammation and expression of inflammatory cytokines in hypercholesterolaemic mice. Dig Liver Dis, 2014, 46(5): 433-439. [20] Abenavoli L, Peta V. Role of adipokines and cytokines in non-alcoholic fatty liver disease. Rev Recent Clin Trials, 2014, 9(3): 134-140. |